CinCor Pharma, Inc. Annual Cash and Cash Equivalents, Period Increase (Decrease) in USD from 2020 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
Summary
CinCor Pharma, Inc. quarterly/annual Cash and Cash Equivalents, Period Increase (Decrease) history and growth rate from 2020 to 2021.
  • CinCor Pharma, Inc. Cash and Cash Equivalents, Period Increase (Decrease) for the quarter ending March 31, 2022 was $28M.
  • CinCor Pharma, Inc. annual Cash and Cash Equivalents, Period Increase (Decrease) for 2021 was $111M, a 657% increase from 2020.
Cash and Cash Equivalents, Period Increase (Decrease), Annual (USD)
Cash and Cash Equivalents, Period Increase (Decrease), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $111M +$95.9M +657% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-22
2020 $14.6M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.